RecruitingNCT01210274

Characterization of the Mechanisms of Resistance to Azacitidine

Studying Acute myeloid leukaemia with myelodysplasia-related features

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Centre Hospitalier Universitaire de Nice
Enrollment: 250 enrolled
Eligibility: 18 years · All sexes
Timeline: 2010 – 2025

Study locations (4)

CH d'Antibes, Antibes, France
CHU de Nice - Hôpital de l'Archet, Nice, France
Centre Antoine Lacassagne, Nice, France
CH Princesse Grace, Monaco, Monaco

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01210274 on ClinicalTrials.gov

Other trials for Acute myeloid leukaemia with myelodysplasia-related features

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT04802161
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
National Cancer Institute (NCI)

See all trials for Acute myeloid leukaemia with myelodysplasia-related features →

← Back to all trials